Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Cutler

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|October 3, 2008
The discovery and early validation of novel plasma biomarkers in mild-to-moderate Alzheimer's disease patients responding to treatment with rosiglitazoneEmma L Akuffo, John B Davis, Steven M Fox, et al.
Proteomics. Clinical Applications|December 8, 2010
Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer's disease in human plasmaPaul Cutler, Emma L Akuffo, Wanda M Bodnar, et al.
Plos One|January 28, 2017
A Novel Positron Emission Tomography (PET) Approach to Monitor Cardiac Metabolic Pathway Remodeling in Response to Sunitinib MalateAlice C O'Farrell, Rhys Evans, Johanna M U Silvola, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|October 3, 2008
The discovery and early validation of novel plasma biomarkers in mild-to-moderate Alzheimer's disease patients responding to treatment with rosiglitazoneEmma L Akuffo, John B Davis, Steven M Fox, et al.
Proteomics. Clinical Applications|December 8, 2010
Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer's disease in human plasmaPaul Cutler, Emma L Akuffo, Wanda M Bodnar, et al.
Plos One|January 28, 2017
A Novel Positron Emission Tomography (PET) Approach to Monitor Cardiac Metabolic Pathway Remodeling in Response to Sunitinib MalateAlice C O'Farrell, Rhys Evans, Johanna M U Silvola, et al.
Pageof 5